Third-party tested · 1–3 day shippingShop the catalog

Research Journal

Insights, science, and exploration from Emetrix Research Labs.

regulatory · August 27, 2026

FDA Advisory Panel Votes to Recommend Broader Compounding Access for Six Peptides

An FDA advisory panel voted to recommend six of seven reviewed peptides — BPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semax — for broader access through compounding pharmacies, while agency scientists cautioned that safety data remain incomplete.

metabolic · August 24, 2026

Retatrutide: Triple-Agonist Pharmacology in Current Metabolic Research

An updated look at retatrutide's GIP/GLP-1/glucagon receptor agonism and what the accumulating trial and preclinical record describes.

cognitive · August 20, 2026

Semax: BDNF Modulation and Neuropeptide Research

Semax, an ACTH(4-10) analog, is studied for neurotrophic signaling. A review of BDNF findings, model systems, and translational gaps.

longevity · August 17, 2026

NAD+ and Its Precursors: Redox Cofactor Research in Aging Models

NAD+ availability governs sirtuin and PARP activity. An overview of precursor pharmacology, tissue distribution questions, and model limitations.

longevity · August 13, 2026

SS-31 (Elamipretide): Cardiolipin Targeting in Mitochondrial Research

SS-31 binds cardiolipin on the inner mitochondrial membrane. A review of bioenergetic findings, tissue models, and interpretation caveats.

metabolic · August 10, 2026

MOTS-c: Mitochondrial-Derived Peptide Signaling and Metabolic Research

MOTS-c sits at the intersection of mitochondrial genetics and metabolic regulation. A review of AMPK signaling findings and exercise-mimetic model data.

growth · August 6, 2026

CJC-1295: Sustained GHRH Analog Signaling in Endocrine Research

How CJC-1295's extended half-life shapes growth hormone pulse studies, and what preclinical literature reports about its secretagogue profile.

regenerative · August 3, 2026

BPC-157: Current Research Landscape in Tissue Repair Signaling

A laboratory overview of BPC-157, covering angiogenic signaling, reported findings in tendon and gastrointestinal models, and open methodological questions.

cognitive · July 30, 2026

Delta Sleep-Inducing Peptide (DSIP): Neuromodulatory Signaling in Sleep Research

A laboratory research overview of DSIP, including mechanism, reported findings, and areas of ongoing investigator interest.

metabolic · July 27, 2026

Retatrutide Phase III Trial Reports ~30% Weight Reduction

A research-oriented overview of the latest Phase III findings on retatrutide, the triple GIP/GLP-1/glucagon receptor agonist reshaping obesity pharmacology research.

metabolic · July 23, 2026

Retatrutide: A Breakthrough Triple-Agonist in Metabolic Research

An overview of retatrutide, the investigational GIP/GLP-1/glucagon triple receptor agonist generating substantial interest across metabolic and obesity research programs.

regenerative · July 20, 2026

BPC-157 in Gastrointestinal Tissue Regeneration Models

BPC-157 has been studied in preclinical gastrointestinal injury models for effects on epithelial restitution, vascular remodeling, and extracellular matrix responses. The literature remains largely mechanistic and model-dependent, with substantial need for standardized in vitro systems.

regenerative · July 17, 2026

TB-500 in Experimental Tendon Repair Models

TB-500 is commonly discussed as a synthetic peptide related to thymosin beta-4, a regulator of actin dynamics and tissue repair signaling. In tendon research, its relevance centers on cell migration, extracellular matrix remodeling, angiogenic signaling, and inflammation resolution in preclinical systems.

regenerative · July 16, 2026

GHK-Cu Overview: Copper Tripeptide Signaling in Regenerative Research

A laboratory research overview of GHK-Cu, including mechanism, reported findings, and areas of ongoing investigator interest.

metabolic · July 13, 2026

Semaglutide Signaling Across Metabolic Research Models

Semaglutide is a long-acting glucagon-like peptide-1 receptor agonist widely studied in metabolic research systems. Its mechanisms are best understood as integrated effects on nutrient sensing, endocrine secretion, gastric motility, and central appetite circuits.

metabolic · July 10, 2026

Tirzepatide Dual Agonism in Metabolic Research Models

Tirzepatide is used experimentally to interrogate coordinated GIP and GLP-1 receptor signaling in metabolic systems. Preclinical studies suggest that its dual agonism alters glucose handling, energy balance, and adipose biology through mechanisms not fully explained by GLP-1 receptor engagement alone.

longevity · July 9, 2026

Epitalon Research Notes: Pineal Signaling and Telomere-Related Endpoints

A laboratory research overview of Epitalon, including mechanism, reported findings, and areas of ongoing investigator interest.

metabolic · July 6, 2026

Retatrutide and the Triple Agonist Research Landscape

Retatrutide has become a reference molecule for studying coordinated GLP-1, GIP, and glucagon receptor agonism in metabolic research models. The current landscape emphasizes receptor pharmacology, energy-balance mechanisms, and unresolved questions about tissue selectivity and translational interpretation.

metabolic · July 3, 2026

Tesamorelin Models Clarify Visceral Adipose Tissue Remodeling

Tesamorelin is a stabilized growth hormone-releasing hormone analog used experimentally to interrogate somatotropic control of adipose compartments. In visceral adipose tissue studies, investigators focus on lipolysis, adipocyte phenotype, inflammatory tone, and imaging-correlated tissue remodeling.

regenerative · July 2, 2026

BPC-157 Research Overview: Tissue Repair Signaling in Preclinical Models

A laboratory research overview of BPC-157, including mechanism, reported findings, and areas of ongoing investigator interest.

growth · June 29, 2026

Ipamorelin Selectivity in Growth Hormone Secretagogue Models

Ipamorelin is commonly used as a selective growth hormone secretagogue in preclinical endocrine research. Its value lies in separating ghrelin receptor-mediated GH release from broader pituitary-adrenal and prolactin-associated effects observed with earlier peptidyl secretagogues.

growth · June 26, 2026

CJC-1295 DAC and Prolonged GHRH Analog Exposure

CJC-1295 is a synthetic growth hormone-releasing hormone analog engineered to extend exposure through a drug affinity complex. In preclinical and analytical models, the DAC strategy illustrates how covalent albumin association can alter peptide persistence, receptor engagement, and experimental design.

growth · June 25, 2026

CJC-1295 in Research: Extending GHRH Half-Life for Pulsatile GH Studies

A laboratory research overview of CJC-1295, including mechanism, reported findings, and areas of ongoing investigator interest.

immunity · June 22, 2026

LL-37 Studies at the Innate Immunity Interface

LL-37, the processed form of human cathelicidin hCAP18, remains a central model for studying antimicrobial peptides in immune regulation. Current laboratory work emphasizes its context-dependent effects on membranes, nucleic acids, inflammatory signaling, and host–microbe interactions.

immunity · June 19, 2026

Thymosin Alpha-1 in Immunomodulation Research Models

Thymosin alpha-1 has been studied as a small peptide regulator of innate and adaptive immune signaling. In vitro and preclinical studies suggest context-dependent effects on dendritic cells, T-cell polarization, interferon pathways, and inflammatory cytokine balance.

longevity · June 18, 2026

FOXO4-DRI: Senolytic Peptide Research and Cellular Senescence Endpoints

A laboratory research overview of FOXO4-DRI, including mechanism, reported findings, and areas of ongoing investigator interest.

longevity · June 15, 2026

Epithalon and Telomerase Activity in Cell Lines

Epithalon has been studied as a short synthetic peptide associated with telomerase modulation in selected cell culture systems. The evidence remains model-dependent, with assay design, cell lineage, and baseline telomerase status strongly shaping interpretation.

peptides · June 12, 2026

Melanotan II Binding Across Melanocortin Receptor Models

Melanotan II remains a useful probe for studying melanocortin receptor pharmacology, especially where subtype selectivity and assay context are central questions. Binding studies show high-affinity engagement across several melanocortin receptor subtypes, with important caveats from model system, species, and readout design.

peptides · June 11, 2026

Melanotan-2 Research Overview: Melanocortin Receptor Pharmacology

A laboratory research overview of Melanotan-2, including mechanism, reported findings, and areas of ongoing investigator interest.

peptides · June 8, 2026

PT-141 Studies in Melanocortin Receptor Signaling

PT-141, also known as bremelanotide, is a cyclic melanocortin peptide used in laboratory studies of central receptor signaling and neuroendocrine control. Preclinical work has helped distinguish melanocortin receptor subtype activity, downstream second-messenger effects, and circuit-level responses in research models.

cognitive · June 5, 2026

Selank Mechanism Studies in Anxiety Research Models

Selank is a synthetic tuftsin-derived peptide examined in preclinical anxiety and cognitive models. Current mechanism investigations emphasize GABAergic tone, monoamine signaling, peptidase resistance, and immune-neural interactions rather than a single receptor-defined pathway.

methodology · June 4, 2026

L-Glutathione in Laboratory Research: Redox Balance and Assay Considerations

A laboratory research overview of L-Glutathione, including mechanism, reported findings, and areas of ongoing investigator interest.

cognitive · June 1, 2026

Semax Modulation of Rodent BDNF Expression

Rodent studies have linked Semax exposure with altered BDNF-related signaling in hippocampal and cortical tissue. The cognitive relevance remains preclinical, with interpretation depending on timing, brain region, stress state, and assay design.

longevity · May 29, 2026

MOTS-c Research at the Mitochondrial Longevity Interface

MOTS-c is a short mitochondrial-derived peptide studied for its roles in metabolic stress signaling, nuclear transcriptional adaptation, and age-associated tissue resilience. Preclinical studies suggest it may connect mitochondrial status to conserved pathways relevant to longevity biology.

cognitive · May 28, 2026

Semax Research Notes: Neurotrophic and Cognitive-Endpoint Studies

A laboratory research overview of Semax, including mechanism, reported findings, and areas of ongoing investigator interest.

longevity · May 25, 2026

SS-31 Binding Studies at the Cardiolipin Interface

SS-31 remains a useful probe for studying cardiolipin-rich mitochondrial membranes in aging biology. Binding studies suggest a context-dependent interaction that may influence membrane organization, cytochrome c behavior, and respiratory stability in preclinical research models.

immunity · May 22, 2026

KPV Tripeptide Studies in Experimental Inflammation

KPV is a C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone studied for immunomodulatory activity in vitro and in preclinical inflammation models. Investigators have focused on epithelial-barrier signaling, macrophage cytokine output, and NF-kB-linked inflammatory pathways.

metabolic · May 21, 2026

MOTS-c Research Notes: Mitochondrial-Derived Peptide Signaling in Metabolism

A laboratory research overview of MOTS-c, including mechanism, reported findings, and areas of ongoing investigator interest.

cognitive · May 18, 2026

Cerebrolysin Peptide Fraction in Cognitive Neurology Models

Cerebrolysin is a complex peptide and amino acid fraction studied for neurotrophic-like effects in laboratory models of cognitive impairment. Preclinical studies suggest activity across synaptic plasticity, neuronal survival, inflammation, and metabolic resilience, though mechanistic attribution remains technically difficult.

regenerative · May 15, 2026

GHK-Cu in Preclinical Skin Regeneration Research

GHK-Cu is a naturally occurring copper-binding tripeptide studied for matrix remodeling, wound-associated signaling, and cellular responses relevant to skin repair. Laboratory findings suggest activity across fibroblast behavior, collagen regulation, inflammation-associated pathways, and oxidative stress models.

longevity · May 14, 2026

NAD+ in Research: Cellular Energetics and Sirtuin-Pathway Endpoints

A laboratory research overview of NAD+, including mechanism, reported findings, and areas of ongoing investigator interest.

cognitive · May 11, 2026

DSIP Studies at the Sleep Cognition Interface

Delta sleep-inducing peptide remains an unsettled molecule in sleep and cognition research. Preclinical studies suggest possible links to arousal regulation, stress responsivity, and memory-associated neurophysiology, but assay limitations and inconsistent replication continue to shape interpretation.

methodology · May 8, 2026

Peptide Reconstitution Practices for Reproducible Laboratory Handling

Peptide reconstitution is a small procedural step with disproportionate effects on analytical reliability. In research models, solvent selection, concentration planning, and storage discipline can determine whether a peptide behaves as expected or introduces avoidable variability.

cognitive · May 7, 2026

Selank Research Overview: Anxiolytic Peptide Signaling in Preclinical Models

A laboratory research overview of Selank, including mechanism, reported findings, and areas of ongoing investigator interest.

methodology · May 4, 2026

Cold-Chain Handling of Research Peptides

Peptide integrity can be affected by temperature excursions, moisture, adsorption, and repeated freeze–thaw exposure. For in vitro and preclinical research programs, cold-chain handling is less a logistical formality than a core variable in assay reproducibility.

methodology · May 1, 2026

Interpreting Certificates of Analysis in Laboratory Research

A certificate of analysis is a compact record of identity, purity, and analytical release criteria, not a substitute for experimental validation. Researchers should read CoAs as traceable methodological documents and assess whether each assay supports the intended in vitro or preclinical use.

regenerative · April 30, 2026

TB-500 (Thymosin Beta-4 Fragment): Actin-Binding Peptide Research Overview

A laboratory research overview of TB-500, including mechanism, reported findings, and areas of ongoing investigator interest.

methodology · April 27, 2026

HPLC Purity Standards for Research Peptide Characterization

High-performance liquid chromatography remains a central method for assessing peptide purity in laboratory research workflows. Interpreting HPLC purity requires attention to chromatographic conditions, detection wavelength, orthogonal identity testing, and the limitations of percent-area reporting.

methodology · April 24, 2026

Mass Spectrometry Verification of Peptide Identity

Peptide identity cannot be inferred reliably from nominal synthesis records or chromatographic retention alone. Mass spectrometry provides orthogonal evidence through intact mass, isotope distribution, and fragmentation behavior, provided sample handling and data interpretation are controlled.

regulatory · April 20, 2026

Research Chemical Compliance Tightens Across 2026 Laboratories

The 2026 regulatory environment for research chemicals is defined less by a single statute than by converging controls on identity, intent, transport, and recordkeeping. Investigators working with in vitro or preclinical materials face a more documentation-intensive landscape.

regulatory · April 17, 2026

FDA Peptide Compounding Guidance Narrows Research Compliance Assumptions

FDA’s recent compounding guidance and enforcement signals place peptide products under closer scrutiny, especially when bulk drug substances, shortage exemptions, or salt forms are involved. Research groups should treat these updates as procurement and documentation issues, not merely pharmacy-sector developments.

methodology · April 13, 2026

Peptide Stability After Reconstitution in Laboratory Workflows

Reconstituted peptide solutions are chemically and physically dynamic systems. Solvent composition, pH, concentration, temperature, container surfaces, and freeze–thaw history can all influence apparent integrity in research models.

regenerative · April 10, 2026

BPC-157 and Angiogenesis in Regenerative Models

BPC-157 has been examined in cell, tissue, and animal models for effects on endothelial behavior and microvascular repair. Preclinical studies suggest angiogenesis-related activity, but the evidence remains heterogeneous and dependent on model design, injury context, and readout selection.

metabolic · April 6, 2026

Mapping Central GLP-1 Receptor Distribution

GLP-1 receptors are sparsely but strategically expressed across central circuits involved in metabolic sensing, autonomic output, and motivated behavior. Preclinical mapping studies suggest that distribution is regionally selective, method-dependent, and functionally linked to both hindbrain and forebrain control nodes.

growth · April 3, 2026

Sermorelin and GHRH Signaling in Growth Research

Sermorelin is widely used as a synthetic analog of the bioactive N-terminal segment of growth hormone–releasing hormone. In laboratory models, it provides a tractable probe of somatotroph signaling, pulsatile growth hormone release, and downstream growth-axis regulation.

growth · March 30, 2026

Hexarelin Responses in Cardiac Tissue Growth Models

Hexarelin has been examined in cardiac models for effects that extend beyond canonical growth hormone secretagogue activity. Preclinical studies suggest context-dependent actions on cardiomyocyte survival, hypertrophic signaling, endothelial behavior, and extracellular matrix remodeling.

growth · March 27, 2026

MK-677 as a Non-Peptide Ghrelin Mimetic

MK-677 is widely used in laboratory studies of the ghrelin receptor and growth hormone secretagogue biology. Preclinical research links its activity to pituitary growth hormone release, IGF-1 signaling, appetite circuits, and species-specific endocrine responses.

metabolic · March 23, 2026

AOD-9604 Lipolytic Fragment Findings in Metabolic Models

AOD-9604 is a modified C-terminal fragment of human growth hormone studied for effects on lipid handling in cell and animal models. Preclinical reports describe altered lipolysis and lipogenesis without the broader growth-promoting profile associated with intact growth hormone.

growth · March 20, 2026

Follistatin 344 in Myostatin Inhibition Research

Follistatin 344 is investigated as a precursor isoform associated with follistatin-mediated antagonism of TGF-β superfamily ligands, including myostatin. In growth-related research models, its relevance lies in how ligand sequestration may alter muscle-cell differentiation, hypertrophy signaling, and tissue remodeling.

growth · March 16, 2026

IGF-1 LR3 Signaling in Growth Model Systems

IGF-1 LR3 is commonly used as a laboratory tool to probe IGF-axis signaling with reduced binding to IGF-binding proteins. In growth-oriented model systems, investigators use it to separate receptor-proximal events from extracellular sequestration effects.

cognitive · March 13, 2026

Oxytocin as a Modulator of Cognitive State

Oxytocin research has moved beyond pair bonding and affiliative behavior into attention, memory, prediction, and stress-linked cognition. Preclinical studies suggest that its effects depend strongly on circuit context, receptor localization, and the computational demands of the task.

cognitive · March 9, 2026

Vasopressin Analogs in Experimental Memory Models

Vasopressin signaling has long been investigated as a modulator of memory consolidation, retrieval, attention, and social recognition. Contemporary work with receptor-selective analogs is helping separate cognitive effects from peripheral endocrine and vascular actions in preclinical systems.

metabolic · March 6, 2026

Adipotide in Preclinical Models of Obesity

Adipotide has been studied as a vascular-targeted peptidomimetic that reduces adipose tissue mass in research models by disrupting blood supply to white fat. Preclinical work suggests metabolic effects coupled to a narrow safety margin, particularly in kidney-associated observations.

metabolic · March 2, 2026

5-Amino-1MQ as an NNMT Probe in Metabolic Research

5-Amino-1MQ is used in preclinical studies to interrogate nicotinamide N-methyltransferase, an enzyme linking NAD metabolism with methyl-donor flux. Current work positions the compound as a laboratory probe for adipose biology, energetic regulation, and metabolic remodeling.

longevity · February 27, 2026

Humanin Peptide in Neuroprotection and Longevity Models

Humanin is a mitochondrial-derived peptide studied for cytoprotective activity in neuronal stress models. Preclinical findings suggest relevance to aging biology, but interpretation remains constrained by model specificity, peptide handling, and incomplete mechanistic resolution.

longevity · February 23, 2026

Pinealon Studies Probe Cortical Aging Mechanisms

Pinealon, a short peptide bioregulator commonly associated with cortical tissue models, is being examined for effects on neuronal stress resilience, gene expression, and age-linked cellular dysfunction. The longevity relevance remains preclinical and depends on stronger mechanistic and reproducibility studies.

cognitive · February 20, 2026

N-acetyl Semax Amidate Stability in Cognitive Research Models

N-acetyl Semax amidate is studied as a modified heptapeptide analog of Semax, with terminal changes intended to alter proteolytic susceptibility. Stability work remains primarily analytical and preclinical, with implications for how investigators design cognitive-model experiments.

peptides · February 16, 2026

Snake Venom Peptides as Experimental Molecular Probes

Snake venoms contain compact peptides that modulate ion channels, receptors, coagulation proteins, and extracellular matrix interactions in research models. Current work emphasizes target deconvolution, synthetic optimization, and assay systems that separate specific peptide pharmacology from complex venom effects.

peptides · February 13, 2026

Conotoxin Peptides as Probes of Ion Channel Function

Conotoxins provide compact, structurally constrained ligands for dissecting ion channel subtype function in vitro. Their value lies less in general potency than in separable selectivity, defined binding sites, and compatibility with electrophysiology, mutagenesis, and structural workflows.

immunity · February 9, 2026

Defensin Biology in Innate Immunity Research

Defensins are small cationic peptides that link barrier defense, microbial sensing, and immune cell signaling in research models. Current studies emphasize their structural diversity, context-dependent antimicrobial activity, and complex roles in inflammatory regulation.

immunity · February 6, 2026

Cathelicidin Peptides in Innate Immune Research

Cathelicidins are cationic host-defense peptides with conserved precursor organization and diverse mature sequences. In research models, they are studied as antimicrobial effectors, immunomodulatory signals, and regulators of barrier tissue responses.

methodology · February 2, 2026

Dose-Response Design Considerations for Peptide Studies

Peptide dose-response experiments require attention to stability, formulation, adsorption, and assay timing. Careful design improves interpretability of potency and efficacy estimates in in vitro and preclinical research models.

regulatory · January 30, 2026

EU Divergence in Research Peptide Oversight

Research peptides occupy an uneven regulatory space across the European Union. Although EU-level frameworks define chemicals, medicinal products, and laboratory safety obligations, classification often turns on intended use, presentation, and national enforcement practice.

regulatory · January 26, 2026

Import Controls in Research Chemical Sourcing

Import controls shape how laboratories procure reference materials, intermediates, and investigational compounds for in vitro and preclinical work. A compliant sourcing program requires classification, documentation, supplier qualification, and clear internal custody controls before materials enter the laboratory.

peptides · January 23, 2026

Peptide receptor targets shaping 2026 preclinical research

Peptide research is moving beyond single-receptor pharmacology toward biased signaling, multi-receptor agonism, and tissue-directed delivery. For 2026, several target classes are likely to receive closer scrutiny in cell systems, organoids, and animal models.